Professional Documents
Culture Documents
Yudiyanta
Pain Sub-Department of Neurology Department
Kasus 1
38 th 1HSMRS LBP + kedua bokong Limitasi ROM terutama pada gerakan fleksi dan rotasi. NPS 6. Neuro Exam: dbn Suhu tubuh 37.8 C. Nyeri tekan diatas vertebra lumbal 4-5 dan dibokong (+).
Pemeriksaan Penunjang yang dianjurkan: A. Lumbal X-Ray B. Lumbal CT Scan C. Lumbal MRI D. ENMG E. Belum perlu
Pemeriksaan Penunjang yang dianjurkan: A. Lumbal X-Ray B. Lumbal CT Scan C. Lumbal MRI D. ENMG E. Belum perlu
Red Flags
Significant trauma history, or minor in older adults Nocturnal pain in supine position with history of cancer Bladder or bowel incontinence or dysfunction Constitutional symptoms:
Fever / chills Weight loss Lymph node enlargement
Compression fracture
Spondylolisthesis
Summary of Evidence on Medications for Acute Low Back Pain (Chou & Huffman, 2007)
Drug Net Benefit
Moderate No evidence No evidence
Inconsistency ?
Some inconsistency No evidence No evidence
Comments
Few data on serious adverse events Evaluated only in patients with radicular LBP No reliable data on risks of abuse or addiction. May cause serious gastrointestinal and cardiovascular adverse event. Insufficient evidence to judge benefits and harms of aspirin and celecoxib for LBP No reliable data on risks of abuse or addiction Little evidence of antispasticity skeletal muscle relaxants baclofen and dantrolene for LBP Mostly evauated in patients with radicular LBP The only trial compared tramadol with an NSAID not available in US
Moderate Moderate
Some inconsistency No
Fair Good
Moderate Moderate
No evidence Yes
Not applicable No
Fair Good
No No evidence
No Not applicable
Fair Poor
Analgesic efficacy, compared with placebo, of treatments for acute and chronic non-specific low back pain.
The Author 2008. Published by Oxford University Press on behalf of the British Society for Machado L A et al. Rheumatology 2009;48:520-527 Rheumatology. All C rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
KASUS 2
Wanita 52 th dg keluhan nyeri punggung bawah menjalar ke tungkai kanan. Riwayat angkat junjung (+), riwayat trauma (-). Pada pemeriksaan nyeri terutama dirasakan saat gerakan ekstensi badan dan miring ke kiri, dan dirasakan lebih nyaman dengan posisi badan fleksi dan menekuk ke kanan. Nyeri sudah dirasakan selama 2 bulan.
Pemeriksaan fisik yang paling sensitif mendukung diagnosis kerja anda: A. Patrick sign B. Kontra-Patrick Sign C. Lasegue sign D. Lasegue silang sign E. Babinski sign
Pada evaluasi lebih lanjut, OS mengeluh nyeri dengan rasa kemeng dan pegal, tidak berdenyut, disertai rasa terbakar, kadang-kadang jika salah posisi nyeri seperti tersetrum sampai ujung kaki. Kesemutan dan tebal2 juga dirasakan. NPS 6.
NE STT
DORSAL HORN
Periphery
PAF
NE 5-HT NE 5-HT 2
Glu NMDA AMPA
STT
mu 5-HT1A
GABA A/B
5-HT3 2
mu
PAF
SP NKA
NK1
GABA InterNeuron
Action of AED
Stafstrom C, 1998
Summary of Evidence on Medications for Sub Acute or Chronic Low Back Pain (Chou & Huffman, 2007)
Drug Net Benefit
Moderate Small To moderate Small to moderate Moderate Moderate
Inconsistency ?
No No
Comments
Asymptomatic elevation of liver function test at therapeutic doses Only TCA have been shown effective for LBP. No evidence for Duloxetine or venlafaxine 1 trial evaluated topiramate for back pain with or w/out radiculopathy No reliable data on risks for abuse or addiction May cause serious GI and CV adverse event. Insufficient evidence to judge benefits and harms of aspirin or celecoxib for LBP No reliable data on risks for abuse or addiction Mostly evaluated in patients with radicular LBP -
Yes
Not applicable
Poor
Some inconsistency No
Fair Fair
Berdasarkan Klinis dan Hasil Lab diatas, analgetik apa yang paling anda rekomendasikan?
A. Paracetamol 650 mg B. Paracetamol 500 mg + Celecoxib 100 mg C. Paracetamol 325 mg + tramadol 37,5 mg D. Celexocib 200 mg+ meloksikam 7,5 mg E. Piroxicam 20 mg + Paracetamol 300 mg F. Asam mefenamat 500 mg + paracetamol 500 mg
Stephan A. Schug Combination analgesia in 2005a rational approach: focus on paracetamoltramadol Published online: 2 June 2006, Clinical Rheumatology 2006
Cont
safety concerns about long-term use: has demonstrated efficacy in the control of a variety of chronic pain states. long-term treatment up to 2 years duration. well-tolerated and has reduction in adverse events a useful add-on analgesic treatment if existing therapy is insufficiently effective
Herniated Disc
BULGING
PROLAPSED
EXTRUDED
SEQUESTRATION
Spondilolisteis
SURGICAL
Indications:
Cauda Equina PROGRESSIVE Motor Loss Intractable Pain Spinal Canal Stenosis
PROGNOSIS on NON-SURGICAL
Treated the patient, not the diagnostic test Recovery:
80 % 3 days to 3 weeks, with or without treatment Up to 90 % resolved in 6-12 weeks
Other Modalities
Back Brace/Corset/Lumbar Support Traction Injections: Inconclusive evidence TENS Hot/Cold Ultrasound
Prevention
Exercise:
Aerobic, back/leg strengthening
Back braces and education about proper lifting techniques Weight loss and smoking cessation
Exercises
Improves pain and function Many programs available, but difficult to make any scientific recommendations for one type versus another
Injections
Epidural injections: Insufficient and conflicting evidence Facet joint injections: No improvement Local/Trigger point injections: Possibly some benefit
Kasus 3
Anda bekerja di klinik panti jompo 65 th dg nyeri terbakar dan rasa tersetrum di dahi sebelah kiri dan di sekitar mata kiri. 3 bl timbul plenting-plenting yang nyeri pada daerah tsb namun sudah sembuh. Saat ini nyeri NPS 8, Nyeri memberat bila tersentuh, terkena sentuhan rambut atau angin.
OS hanya bersedia minum satu jenis obat. Obat mana yang paling anda rekomendasikan?
A. Meloksikam 1x15 mg B. Asam mefenamat 3x500 mg C. Metikobalamin 3x500 mcg D. Parasetamol 3x650 mg E. Amitriptilin 1x12,5 mg
Hasil EKG menunjukkan VES jarang, HHD, dan iskemik anterior. Obat mana yang anda rekomendasikan ? A. Gabapentin 2x75 mg B. Tramadol 2x50 mg C. Metikobalamin 3x500 mcg D. Parasetamol 3x650 mg E. Amitriptilin 1x12,5 mg
Recommendations: First line therapy Second line therapy Lack of or weak efficacy TCAs, gabapentin, pregabalin, and topical lidocaine (evidence level A) Strong opioids, tramadol and capsaicin (evidence level B) Mexiletine and NMDA antagonists (evidence level A)